Cited by 123Drug Solubulity and Delivery SystemsPharmacogenetics and Drug MetabolismPharmaceutical studies and practices

Examination of some factors responsible for a food‐induced increase in absorption of atovaquone.

Open access
Rolan, PE, Mercer, AJ, Weatherley, BC, Holdich, T, Meire, H, Peck, RW, Ridout, G, Posner, J·1994·British Journal of Clinical Pharmacology

Abstract

1. Atovaquone is a potent antiprotozoal slowly and irregularly absorbed after administration as tablets to fasting volunteers. A series of studies was performed to investigate the effects of food, bile and formulation on atovaquone absorption. 2. In 18 healthy male volunteers, a high‐fat breakfast administered 45 min before 500 mg atovaquone as tablets increased AUC by 3.3‐fold (95% CI 2.8‐4.0) and Cmax 5.3‐fold (4.3‐6.6) compared with fasting. 3. The absorption of atovaquone from tablets was examined in 12 healthy male volunteers after an overnight fast, following toast alone, toast with 28 g butter (LOFAT), or toast with 56 g butter (HIFAT). Compared with absorption when fasted, toast had no significant effect but LOFAT increased AUC 3.0‐fold (2.1‐4.2) and Cmax 3.9‐fold (2.6‐5.8). HIFAT increased AUC 3.9‐fold (2.7‐5.5) and Cmax 5.6‐fold (3.8‐8.4). 4. The absorption of atovaquone was examined in nine healthy fasting male volunteers from tablets, an aqueous suspension, and an oily solution/suspension in miglyol (fractionated coconut oil). Compared with tablets, AUC following the aqueous suspension was increased 1.7‐fold (1.0‐2.7) and Cmax 2.4‐fold (1.7‐ 3.5). Following miglyol, AUC was increased to the same extent but Cmax was only increased 1.8‐fold (1.2‐2.6). 5. Atovaquone absorption was examined in eight healthy fasting male volunteers following an i.v. infusion of cholecystokinin octapeptide (CCK‐OP) which decreased gallbladder volume by 82% (73%‐90%) on occasion 1 or saline on occasion 2. AUC(0,12) was increased following CCK‐OP by 1.6‐fold (1.1‐2.4) and Cmax by 1.5‐fold (0.98‐2.4).(ABSTRACT TRUNCATED AT 250 WORDS)

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1365-2125.1994.tb04232.x

Cites

21 of 21 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 3

  1. Mills GL, Lane PA, Weech PK. A guide to lipoprotein technique. New York: Elsevier, 1984.
  2. Kabasakalian P, Katz P, Rosencrantz B, Townley E. Paramaters affecting absorption of griseofulvin in a human subject using urinary extraction data. J pharm Sci 1970; 59: 595-600.
  3. Pozniak A, Yoganathan K, McNicol S, Dixon R, Posner J, Rolan P. Improved bioavailability of atovaquone from a suspension formulation in HIV infected patients. Abstract for the IXth International Conference on AIDS, Berlin, June 1993.

Cited by

Sorted by citations

Authors
Rolan, P., Mercer, A., Weatherley, B., Holdich, T., Meire, H., Peck, R., Ridout, G., & Posner, J.
Affiliations
Wellcome Trust (GB)
Venue
British Journal of Clinical Pharmacology
Publisher
Wiley
Published
1994-01
Volume
37
Issue
1
Pages
13-20
ISSN
  • 0306-5251 (ISSN-L)
  • 1365-2125
OpenAlex
W1996353358
Cited by
123
References
21
Citations by year
2026: 3 · 2025: 1 · 2024: 2 · 2023: 3 · 2022: 2 · 2021: 1 · 2020: 2 · 2019: 2 · 2018: 4 · 2017: 3 · 2016: 3 · 2015: 3 · 2014: 4 · 2013: 3 · 2012: 3
FWCI
6.26
Type
journal article
Language
en
Open access
Locations
  • British Journal of Clinical Pharmacology (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Drug Solubulity and Delivery Systems
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmaceutical studies and practices
Keywords
atovaquone, drug absorption, food effect, high-fat meal, tablet formulation, Miglyol, aqueous suspensions, cholecystokinin octapeptide, bile, antiprotozoal agents, bioavailability
MeSH terms
Adult, Chromatography, High Pressure Liquid, Dietary Fats, Fasting, Food, Humans, Infusions, Intravenous, Intestinal Absorption, Male, Middle Aged, Naphthoquinones, Sincalide, Suspensions, Tablets, Atovaquone

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review